Publications by authors named "Lisa Nilsson"

Claim this Profile
T
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.
Sofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, Joleen J H Traets, Austin George, Lisa M Nilsson, Jonas A Nilsson

Nature· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of KEAP1/NRF2 pathway in non-BRAF mutated squamous cell carcinoma of the thyroid.
Elin Schoultz, Jakob Dahlberg, Lisa M Nilsson, Jozefina J Dzanan, Therese Carlsson, Jonas A Nilsson, Mikael Nilsson

J Pathol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin Sensitivity Controls Activity of Pathogenic CD4+ T Cells in Rheumatoid Arthritis.
Malin C Erlandsson, Eric Malmhäll-Bah, Venkataragavan Chandrasekaran, Karin M E Andersson, Lisa M Nilsson

Cells· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models.
Zhi-Jie Li, Bo He, Alice Domenichini, Jiulia Satiaputra, Kira H Wood, Lisa M Nilsson, Jonas A Nilsson

J Clin Invest· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases.
Joakim W Karlsson, Vasu R Sah, Roger Olofsson Bagge, Irina Kuznetsova, Munir Iqba, Lisa M Nilsson, Jonas A Nilsson

Elife· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Jonas A Nilsson

Cancer Res Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.
Elin M V Forsberg, Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Lisa M Nilsson, Jonas A Nilsson

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma.
Vasu R Sah, Joakim Karlsson, Henrik Jespersen, Mattias F Lindberg, Lisa M Nilsson, Jonas A Nilsson

Melanoma Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft Models.
Lisa M Nilsson, Caroline Vilhav, Joakim W Karlsson, Johan Bourghardt Fagman, Daniel Giglio, Jonas A Nilsson

Gastro Hep Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells.
Frank Liang, Lisa M Nilsson, Fabian Byvald, Azar Rezapour, Helena Taflin, Jonas A Nilsson

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.
Lars Ny, Henrik Jespersen, Joakim Karlsson, Samuel Alsén, Stefan Filges, Lisa M Nilsson, Jonas A Nilsson

Nat Commun· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after Expansion.
Tobias Hofving, Frank Liang, Joakim Karlsson, Ulf Yrlid, Jonas A Nilsson, Ola Nilsson, Lisa M Nilsson

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma.
Elisa Funck-Brentano, Dzeneta Vizlin-Hodzic, Jonas A Nilsson, Lisa M Nilsson

Epigenetics· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
Alexander Biederstädt, Zonera Hassan, Christian Schneeweis, Markus Schick, Lara Schneider, Lisa Nilsson, Jonas Nilsson

Gut· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cells.
Somsundar V Muralidharan, Lisa M Nilsson, Mattias F Lindberg, Jonas A Nilsson

Life Sci Alliance· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of driver events in metastatic uveal melanoma.
Joakim Karlsson, Lisa M Nilsson, Suman Mitra, Samuel Alsén, Ganesh Vilas Shelke, Jonas A Nilsson

Nat Commun· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.
Berglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, Mattias F Lindberg, Elisa Funck-Brentano, Lisa M Nilsson, Jonas A Nilsson

Cell Death Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
Henrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, Ana Carneiro, Hildur Helgadottir, Lisa M Nilsson, Jonas A Nilsson

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice.
Elin M V Forsberg, Mattias F Lindberg, Henrik Jespersen, Samuel Alsén, Roger Olofsson Bagge, Ola Nilsson, Lisa M Nilsson, Jonas A Nilsson

Cancer Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.
Berglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, Mattias F Lindberg, Elisa Funck-Brentano, Lisa M Nilsson, Jonas A Nilsson

Cell Death Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary.
Roger Olofsson Bagge, Akif Demir, Joakim Karlsson, Babak Alaei-Mahabadi, Berglind O Einarsdottir, Lisa M Nilsson, Ola Nilsson, Jonas A Nilsson

JCO Precis Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma.
Somsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, Mattias F Lindberg, Jin Wu, Lisa M Nilsson, Jonas A Nilsson

Cell Death Dis· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.
Henrik Jespersen, Mattias F Lindberg, Marco Donia, Elin M V Söderberg, Rikke Andersen, Lisa M Nilsson, Jonas A Nilsson

Nat Commun· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma.
Somsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, Mattias F Lindberg, Jin Wu, Lisa M Nilsson, Jonas A Nilsson

Cell Death Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
Taral R Lunavat, Su Chul Jang, Lisa Nilsson, Hyun Taek Park, Gabriela Repiska, Jonas A Nilsson

Biomaterials· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis